Tan Wei Liang Partner

Contact
T +603 2081 3999 ext 907
E tan.wei.liang@skrine.com
 

Overview

Wei Liang’s portfolio primarily focuses on mergers & acquisitions, corporate advisory, foreign direct investments, and transactional matters. He also advises on various issues in respect of regulatory compliance in Malaysia.

 

Key Practice Areas

  • Mergers & Acquisitions
  • Corporate Advisory and Transaction
 

  • Part of the Malaysian core team which advised the London Stock Exchange Group on the Malaysian law aspects of its acquisition of the financial data provider Refinitiv for a total enterprise value of USD27 billion from a consortium of investment funds affiliated with Blackstone and Thomson Reuters.

  • Part of the Malaysian core team which advised Arthur J. Gallagher & Co. on the Malaysian law aspects of its acquisition of Willis Tower Watson plc’s treaty reinsurance brokerage operations in a deal valued at more than USD3.25 billion. Willis Tower Watson plc’s treaty reinsurance brokerage operations include a licensed Labuan insurance broker under the purview of the Labuan Financial Services Authority.

  • Part of the Malaysian core team which advised one of Australia’s largest private equity investment firms on the Malaysian law aspects of its potential acquisition of a global biscuits and snacks division, for an indicative consideration of approximately USD2.10 billion.

  • Part of the Malaysian core team which advised Tecan Group AG, a global provider of automated laboratory instruments and solutions which is listed on the SIX Swiss Exchange, on the Malaysian law aspects of its acquisition of US-based Paramit Corporation and its affiliates for a total purchase consideration of USD1.0 billion.

  • Part of the Malaysian core team which advised Greenwood Capital Pte. Ltd., an indirect wholly-owned subsidiary of GIC (Ventures) Pte Ltd (which is Singapore’s sovereign wealth fund) on its subscription of a 16% stake in Sunway Healthcare Sdn Bhd for a subscription consideration of RM750.0 million. The Sunway Healthcare group operates several medical centres in Malaysia and has a presence in Singapore as well.

  • Part of the Malaysian core team which acted for DIF Capital Partners in respect of the Malaysian law aspects of its acquisition of a 51% stake in ib vogt GmbH, a leading global developer in utility-scale PV solar.

  • Acted for Grand Venture Technology Limited, a precision manufacturing solutions provider which is listed on the Singapore Stock Exchange, in respect of its acquisition of a Malaysian precision sheet metal manufacturer, Formach Asia Sdn Bhd, for approximately S$7.8 million.

  • Part of the Malaysian core team which advised SCOR SE, a leading global reinsurer, on the Malaysian law aspects of its global restructuring exercise which involved the restructuring of two foreign Labuan reinsurers, regulatory licence applications and scheme of transfer of reinsurance portfolios. 


  • Part of the Malaysian core team which advised the Reckitt Benckiser group on the Malaysian law aspects of its restructuring exercise which involved the split of its health and hygiene home business units.

  • Advising a China-based company in its establishment of a bird nest processing centre in Malaysia.

Qualifications:
  • Advocate & Solicitor, High Court of Malaya (2017)
  • Barrister-At-Law, The Honourable Society of Lincoln’s Inn, London (2016)
  • LL.B (Hons), University of Reading (2015)